212 related articles for article (PubMed ID: 22722467)
1. CD4/CD8 double negative mycosis fungoides with PD-1 (CD279) expression--a disease of follicular helper T-cells?
Kempf W; Kazakov DV; Cipolat C; Kutzner H; Roncador G; Tomasini D
Am J Dermatopathol; 2012 Oct; 34(7):757-61. PubMed ID: 22722467
[TBL] [Abstract][Full Text] [Related]
2. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides.
Hodak E; David M; Maron L; Aviram A; Kaganovsky E; Feinmesser M
J Am Acad Dermatol; 2006 Aug; 55(2):276-84. PubMed ID: 16844512
[TBL] [Abstract][Full Text] [Related]
3. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
Bosisio FM; Cerroni L
Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
[TBL] [Abstract][Full Text] [Related]
4. Double-positive CD4/CD8 mycosis fungoides: a rarely reported immunohistochemical profile.
Tournier E; Laurent C; Thomas M; Meyer N; Viraben R; Brousset P; Lamant L
J Cutan Pathol; 2014 Jan; 41(1):58-62. PubMed ID: 24134789
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of mycosis fungoides on paraffin-embedded tissue sections.
Izban KF; Hsi ED; Alkan S
Mod Pathol; 1998 Oct; 11(10):978-82. PubMed ID: 9796726
[TBL] [Abstract][Full Text] [Related]
6. Folliculotropic mycosis fungoides: clinicopathological analysis of 17 patients.
Marschalkó M; Erős N; Kontár O; Hidvégi B; Telek J; Hársing J; Jókai H; Bottlik G; Rajnai H; Szepesi Á; Matolcsy A; Kárpáti S; Csomor J
J Eur Acad Dermatol Venereol; 2015 May; 29(5):964-72. PubMed ID: 25406034
[TBL] [Abstract][Full Text] [Related]
7. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
[TBL] [Abstract][Full Text] [Related]
8. CD4/CD8 dual-positive mycosis fungoides: a previously unrecognized variant.
Knapp CF; Mathew R; Messina JL; Lien MH
Am J Dermatopathol; 2012 May; 34(3):e37-9. PubMed ID: 22356917
[TBL] [Abstract][Full Text] [Related]
9. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
[TBL] [Abstract][Full Text] [Related]
10. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG
Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
[TBL] [Abstract][Full Text] [Related]
11. CD4+, CD56+ mycosis fungoides: case report and review of the literature.
Horst BA; Kasper R; LeBoit PE
Am J Dermatopathol; 2009 Feb; 31(1):74-6. PubMed ID: 19155730
[TBL] [Abstract][Full Text] [Related]
12. Most CD8+ cells in skin lesions of CD3+ CD4+ mycosis fungoides are CD3+ T cells that lack CD11b, CD16, CD56, CD57, and human Hanukah factor mRNA.
Wood GS; Dubiel C; Mueller C; Abel EA; Hoppe RT; Edinger A; Weissman I; Warnke RA
Am J Pathol; 1991 Jun; 138(6):1545-52. PubMed ID: 1828937
[TBL] [Abstract][Full Text] [Related]
13. Follicular mycosis fungoides: a histopathologic, immunohistochemical, and genotypic review.
Boone SL; Guitart J; Gerami P
G Ital Dermatol Venereol; 2008 Dec; 143(6):409-14. PubMed ID: 19169213
[TBL] [Abstract][Full Text] [Related]
14. The difficulties in defining follicular T helper phenotype in cutaneous lymphomas.
Guitart J; Gammon B
Am J Dermatopathol; 2013 Aug; 35(6):691. PubMed ID: 23334519
[No Abstract] [Full Text] [Related]
15. CD20 positive mycosis fungoides: a case report.
Sen F; Kang S; Cangiarella J; Kamino H; Hymes K
J Cutan Pathol; 2008 Apr; 35(4):398-403. PubMed ID: 18261116
[TBL] [Abstract][Full Text] [Related]
16. Canine cutaneous epitheliotropic lymphoma (mycosis fungoides) is a proliferative disorder of CD8+ T cells.
Moore PF; Olivry T; Naydan D
Am J Pathol; 1994 Feb; 144(2):421-9. PubMed ID: 7906096
[TBL] [Abstract][Full Text] [Related]
17. Intertriginous mycosis fungoides: a distinct presentation of cutaneous T-cell lymphoma that may be caused by malignant follicular helper T cells.
Gammon B; Guitart J
Arch Dermatol; 2012 Sep; 148(9):1040-4. PubMed ID: 22986857
[TBL] [Abstract][Full Text] [Related]
18. The prognosis of early mycosis fungoides is not influenced by phenotype and T-cell clonality.
Massone C; Crisman G; Kerl H; Cerroni L
Br J Dermatol; 2008 Sep; 159(4):881-6. PubMed ID: 18644018
[TBL] [Abstract][Full Text] [Related]
19. Expression of programmed death-1 in primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma.
Cetinözman F; Jansen PM; Willemze R
Am J Surg Pathol; 2012 Jan; 36(1):109-16. PubMed ID: 21989349
[TBL] [Abstract][Full Text] [Related]
20. The T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides.
Lu D; Duvic M; Medeiros LJ; Luthra R; Dorfman DM; Jones D
Am J Clin Pathol; 2001 Mar; 115(3):413-21. PubMed ID: 11242798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
